D.E. Shaw & Co
WGS icon

D.E. Shaw & Co’s GeneDx Holdings WGS Stock Holding History

D.E. Shaw & Co’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
38,200
+6,900
+22% +$392K ﹤0.01% 2973
2026
Q1 		$2.01M Buy
31,300
+14,800
+90% +$1.35M ﹤0.01% 2904
2025
Q4 		$2.15M Sell
16,500
-16,700
-50% -$2.29M ﹤0.01% 3001
2025
Q3 		$3.58M Buy
33,200
+1,000
+3% +$109K ﹤0.01% 2510
2025
Q2 		$2.97M Buy
32,200
+26,200
+437% +$2.06M ﹤0.01% 2435
2025
Q1 		$531K Buy
6,000
+3,100
+107% +$269K ﹤0.01% 3474
2024
Q4 		$223K Buy
+2,900
New +$203K ﹤0.01% 4037

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

D.E. Shaw & Co's WGS Position: Q2 2026 in Review

D.E. Shaw & Co increased its GeneDx Holdings (WGS) stake by 106% in Q2 2026, buying an estimated $1.14M and bringing the position to 38,877 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

D.E. Shaw & Co first reported a position in WGS in Q1 2021 and has held it in 15 quarters since. The position peaked at $35.4M in Q1 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • D.E. Shaw & Co held 38,877 shares of GeneDx Holdings worth $2.67M as of Q2 2026.
  • D.E. Shaw & Co bought 19,974 GeneDx Holdings shares in Q2 2026, an estimated $1.14M.
  • GeneDx Holdings made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2952 holding.
  • D.E. Shaw & Co first reported a position in GeneDx Holdings in Q1 2021 and has held it in 15 quarters since.
  • D.E. Shaw & Co's GeneDx Holdings position peaked at $35.4M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.